Notice of Intent to Sole Source – Becton, Dickinson and Company

This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested. This procurement is for BD Rhapsody HT Xpress Package, BD Rhapsody™ 8-Lane Cartridge, BD Rhapsody™ Tagmentation and Supplemental Reagents Kit, BD Rhapsody™ Multiomic ATAC-Seq Amplification Kit and Rhapsody Scanner Upgrade Kit. These kits provide the necessary reagents for the preparation of single cell mRNA and ATAC-Seq libraries simultaneously with the BD Rhapsody™ Single-Cell Analysis system to generate multiomic analysis of open chromatin accessibility and transcriptome of single cells in one experiment. BD Biosciences is the only vendor that provides high quality reagents and compatible with its (BD) Rhapsody single-cell analysis system that we have in the lab. This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 –Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasonably available. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements. Interested parties may identify their interest and capabilities in response to this posting. The determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government. Comments to this announcement, referencing this posting number, may be submitted to the NIH, Clinical Center, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, to the attention of Ryssa Nix, Contract Specialist via email to [email protected] by close date.